Vyne Therapeutics Inc
NASDAQ:VYNE
Vyne Therapeutics Inc
NASDAQ:VYNE
Price:
0.65
USD
Market Cap:
$21.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Vyne Therapeutics Inc
NASDAQ:VYNE
|
US |
|
P
|
PagerDuty Inc
F:2TY
|
US |
|
A
|
Atlassian Corporation PLC
F:59A
|
UK |
|
C
|
Cemex SAB de CV
F:CEXA
|
MX |
|
UniCredit SpA
MIL:UCG
|
IT |
|
B
|
Banco Santander SA
XMUN:BSD2
|
ES |
|
C
|
Central Garden & Pet Co
F:GP7
|
US |
|
Bollore SE
F:BOP
|
FR |
|
A
|
Adobe Inc
XBER:ADB
|
US |
|
C
|
CVS Health Corp
XMUN:CVS
|
US |
|
M
|
McDonald's Corp
BMV:MCD
|
US |
|
Fortescue Metals Group Ltd
F:FVJA
|
AU |
|
Ferrari NV
NYSE:RACE
|
IT |
|
M
|
Marathon Petroleum Corp
F:MPN
|
US |
|
W
|
Workday Inc
F:W7D
|
US |
|
F
|
First Citizens BancShares Inc (Delaware)
F:FC6A
|
US |
|
B
|
Baloise Holding AG
DUS:BLON
|
CH |
|
M
|
McDonald's Corp
XMUN:MDO
|
US |
Fundamental Analysis
Financials
Revenue & Expenses Breakdown
Vyne Therapeutics Inc
Vyne Therapeutics Inc
Efficiency
Earnings Waterfall
Vyne Therapeutics Inc
Vyne Therapeutics Inc
